Your browser doesn't support javascript.
loading
Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation.
Yu, Ju-Tao; Hu, Xiao-Wei; Yang, Qin; Shan, Run-Run; Zhang, Yao; Dong, Ze-Hui; Li, Hai-di; Wang, Jia-Nan; Li, Chao; Xie, Shuai-Shuai; Dong, Yu-Hang; Ni, Wei-Jian; Jiang, Ling; Liu, Xue-Qi; Wei, Biao; Wen, Jia-Gen; Liu, Ming-Ming; Chen, Qi; Yang, Ya-Ru; Zhang, Gui-Yang; Zang, Hong-Mei; Jin, Juan; Wu, Yong-Gui; Zhong, Xiang; Li, Jun; Wang, Wei; Meng, Xiao-Ming.
Affiliation
  • Yu JT; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Hu XW; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China; Department of Clinical Pharmacy, Anhui Provinci
  • Yang Q; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China; Department of Clinical Pharmacology, Second Hos
  • Shan RR; School of Life Sciences, Anhui Medical University, Hefei, China.
  • Zhang Y; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Dong ZH; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Li HD; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Wang JN; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Li C; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Xie SS; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Dong YH; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Ni WJ; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Jiang L; Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Liu XQ; Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Wei B; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Wen JG; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Liu MM; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Chen Q; School of Life Sciences, Anhui Medical University, Hefei, China.
  • Yang YR; Department of Clinical Pharmacology, Second Hospital of Anhui Medical University, Hefei, China.
  • Zhang GY; Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, China.
  • Zang HM; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Jin J; Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, China.
  • Wu YG; Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Zhong X; Department of Nephrology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Li J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Wang W; Department of Urology, Institute of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, China. Electronic address: wangweimiwai@126.com.
  • Meng XM; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China. Electronic address: mengxiaoming@ahmu.edu.cn.
Kidney Int ; 102(4): 828-844, 2022 10.
Article in En | MEDLINE | ID: mdl-35752325
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Inhibitor of Metalloproteinase-2 / Acute Kidney Injury Type of study: Prognostic_studies Limits: Animals Language: En Journal: Kidney Int Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Inhibitor of Metalloproteinase-2 / Acute Kidney Injury Type of study: Prognostic_studies Limits: Animals Language: En Journal: Kidney Int Year: 2022 Type: Article Affiliation country: China